American Well (AMWL) Insider Notice: 13,593 RSU Shares to Be Sold
Rhea-AI Filing Summary
Form 144 notice from American Well Corporation (AMWL) shows a proposed sale of 13,593 common shares, with an aggregate market value of $98,549.25, to be sold approximately on 08/19/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The shares were acquired as restricted stock units from the issuer on 06/18/2025 and the acquisition/payment date is listed as 06/18/2025. The filer reports no securities sold during the past three months. The form includes the standard representation that the selling person is not aware of any undisclosed material adverse information and references Rule 144 and Rule 10b5-1 considerations.
Positive
- Transparent compliance: The filer submitted a Form 144 with broker details, dates, and quantities, meeting Rule 144 disclosure requirements.
- Securities were acquired as RSUs, indicating these are company-issued restricted awards rather than open-market purchases, and the filer attests to no undisclosed material information.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice of sale for recently vested RSUs; small position relative to total shares outstanding, appears compliance-focused.
The filing documents a proposed sale of 13,593 common shares acquired as restricted stock units on 06/18/2025, to be transacted via Morgan Stanley on the NYSE around 08/19/2025. The aggregate market value is $98,549.25 against 14,504,796 shares outstanding, indicating the transaction is a small fraction of total equity. No sales in the prior three months are reported. From a trading-impact perspective, the size is immaterial to market supply, and the notice follows Rule 144 disclosure practices.
TL;DR: Disclosure appears procedurally correct; signer affirms no undisclosed material information and notes Rule 10b5-1 language.
The form includes customary attestation language regarding absence of undisclosed material adverse information and mentions the potential applicability of a Rule 10b5-1 trading plan. The sale involves RSUs granted by the issuer and processed through a broker, which aligns with standard executive equity monetization. The filing provides the essential dates and quantities required under Form 144, supporting transparency and regulatory compliance.
FAQ
What does the AMWL Form 144 disclose about the proposed sale?
How and when were the shares being sold acquired according to the filing?
Does the filing report any other securities sold by the person in the past three months?
Which broker and exchange are named in the Form 144 for the transaction?
What representation does the seller make about material information?